文献速递系统性红斑狼疮

1000种蛋白定量平面阵列筛选发现新型狼疮肾炎尿液蛋白生物标志物

Quantitative planar array screen of 1000 proteins uncovers novel urinary protein biomarkers of lupus nephritis.
PubMed 文献 · Ann Rheum Dis · 2020-07-10

该研究用定量平面蛋白微阵列检测SLE患者尿液中1000种蛋白,发现64种显著升高,其中17种经ELISA在独立队列验证。尿液Angptl4、L-selectin、TPP1、TGFβ1等区分活动性肾型与活动性非肾型SLE,在特异性、敏感性和阳性预测值方面优于抗dsDNA、C3和C4。尿液Angptl4、L-selectin和TGFβ1是追踪LN疾病活动的潜在生物标志物。

要点

  • 尿液Angptl4(AUC=0.96)区分活动性肾型与活动性非肾型SLE的效能最高。
  • 尿液L-selectin、Angptl4和TGFβ1在纵向随访中最能追踪同期或即将发生的疾病 flare。
  • 单细胞RNA测序显示部分LN尿液升高蛋白亦在肾脏驻留细胞或浸润免疫细胞中表达。

核心结论

  • 无偏平面阵列筛选1000种蛋白发现尿液Angptl4、L-selectin和TGFβ1是追踪LN疾病活动的潜在生物标志物。

研究设计与样本

  • 研究用新型定量平面蛋白微阵列检测SLE患者尿液中的1000种蛋白,并在独立SLE队列(含inactive、ANR和AR患者)、同期肾活检队列及纵向队列中验证。

主要发现

  • 筛选1000种蛋白发现64种在SLE尿液中显著升高,其中17种经ELISA在独立队列验证。
  • 尿液Angptl4(AUC=0.96)、L-selectin(AUC=0.86)、TPP1(AUC=0.84)、TGFβ1(AUC=0.78)、thrombospondin-1(AUC=0.73)、FOLR2(AUC=0.72)、PDGFR-β(AUC=0.67)和PRX2(AUC=0.65)区分AR与ANR SLE,在特异性、敏感性和阳性预测值方面优于抗dsDNA、C3和C4。
  • 多变量回归分析中,尿液Angptl4、L-selectin、TPP1和TGFβ1与疾病活动度高度相关,即使校正人口学变量后仍显著。
  • 在纵向随访的SLE患者中,尿液L-selectin(其次为尿液Angptl4和TGFβ1)最能追踪同期或即将发生的疾病 flare。
  • 基于单细胞RNA测序分析,部分LN尿液中升高的蛋白亦在LN肾脏的驻留肾细胞或浸润免疫细胞中表达。

关键数值与推荐

  • 尿液Angptl4区分AR与ANR SLE的AUC=0.96。
  • 尿液L-selectin区分AR与ANR SLE的AUC=0.86。
  • 尿液TPP1区分AR与ANR SLE的AUC=0.84。
  • 尿液TGFβ1区分AR与ANR SLE的AUC=0.78。

临床怎么用

  • 尿液Angptl4、L-selectin和TGFβ1可作为追踪LN疾病活动的候选生物标志物,其区分AR与ANR的效能优于抗dsDNA、C3和C4。
  • 尿液L-selectin在纵向随访中 best 追踪同期或即将发生的疾病 flare,可辅助监测LN病情变化。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The goal of these studies is to discover novel urinary biomarkers of lupus nephritis (LN). METHODS: Urine from systemic lupus erythematosus (SLE) patients was interrogated for 1000 proteins using a novel, quantitative planar protein microarray. Hits were validated in an independent SLE cohort with inactive, active non-renal (ANR) and active renal (AR) patients, in a cohort with concurrent renal biopsies, and in a longitudinal cohort. Single-cell renal RNA sequencing data from LN kidneys were examined to deduce the cellular origin of each biomarker. RESULTS: Screening of 1000 proteins revealed 64 proteins to be significantly elevated in SLE urine, of which 17 were ELISA validated in independent cohorts. Urine Angptl4 (area under the curve (AUC)=0.96), L-selectin (AUC=0.86), TPP1 (AUC=0.84), transforming growth factor-β1 (TGFβ1) (AUC=0.78), thrombospondin-1 (AUC=0.73), FOLR2 (AUC=0.72), platelet-derived growth factor receptor-β (AUC=0.67) and PRX2 (AUC=0.65) distinguished AR from ANR SLE, outperforming anti-dsDNA, C3 and C4, in terms of specificity, sensitivity and positive predictive value. In multivariate regression analysis, urine Angptl4, L-selectin, TPP1 and TGFβ1 were highly associated with disease activity, even after correction for demographic variables. In SLE patients with serial follow-up, urine L-selectin (followed by urine Angptl4 and TGFβ1) were best at tracking concurrent or pending disease flares. Importantly, several proteins elevated in LN urine were also expressed within the kidneys in LN, either within resident renal cells or infiltrating immune cells, based on single-cell RNA sequencing analysis. CONCLUSION: Unbiased planar array screening of 1000 proteins has led to the discovery of urine Angptl4, L-selectin and TGFβ1 as potential biomarker candidates for tracking disease activity in LN.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Vanarsa K, Soomro S, Zhang T, et al. Quantitative planar array screen of 1000 proteins uncovers novel urinary protein biomarkers of lupus nephritis. Ann Rheum Dis. 2020. PMID: 32651195. doi:10.1136/annrheumdis-2019-216312

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。